Waters' Center of Innovation for Metabolomics
The Waters' Centers of Innovation Program supports the efforts of scientists facilitating breakthroughs in health and life science research, environmental protection, and many other areas. The Georgetown COI employs primarily a modern mass spectrometry approach for the analysis of metabolites and other small molecules. Areas of particular focus include dissection of stress signaling and injury responses, cancer, neurologic diseases, transplantation medicine, as well as a variety of medical applications. Another area of focus is development of biomarkers with relevance to environmental science, early disease diagnosis, and homeland security. The Center Of Innovation For Metabolomics was awarded to Georgetown Univ. in 2011 and is directed by Prof. Albert J. Fornace Jr. and Dr. Amrita Cheema is the Co-Director.
NEWS & PUBLICATIONS
GUMC Selected as Water Center of Innovation
MILFORD, MA (July 7, 2011) — Waters Corporation today welcomed the metabolomics program at Georgetown University Medical Center (GUMC) into its Centers of Innovation Program.
Blood Test Identifies those At-Risk of Cognitive Decline
WASHINGTON (March 9, 2014) — Researchers have discovered and validated a blood test that can predict with greater than 90 percent accuracy if a healthy person will develop mild cognitive impairment or Alzheimer’s disease.
2016
Long chain polyunsaturated lipid acyls found in non human primates exposed to ionizing radiation
A multi-omic approach to assess metabolic changes in the host-microbiome axis after injury
Development of saliva metabolomics to assess injury responses to radiation
Research suggests that gut bacteria metabolites could help prevent cancer
2015
Serum metabolites of malignant pancreatic cancer in a mouse model
Development of an informatics approach to assess LC-MS datasets possessing high experimental noise.